MannKind Reports Positive Phase 1b Results for Inh...
Category : Clinical Trial Update 31 July 2026Study Shows Favorable Safety Profile for Inhaled Nintedanib in IPF Patients MannKind Corporation...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Kaigene Licenses Autoimmune Drug Candidate KG006 t...
Category : Licensing/Collaboration Deal 31 July 2026Partnership Aims to Expand Autoimmune Treatment Development in Japan Kaigene, Inc., a biotechnolo...
ViiV Healthcare Shares New HIV Treatment and Preve...
Category : Clinical Trial Update 31 July 2026New Studies Highlight Progress in Long-Acting HIV Care GSK plc announced that ViiV Healthcare pre...
Bain Capital to Acquire Vitabiotics, Plans to Acce...
Category : Merger/Acquisition 30 July 2026Bain Capital Signs Agreement to Acquire Vitabiotics Bain Capital, a global private investment fir...
ProMIS Reports Positive Interim Phase 1b Results f...
Category : Clinical Trial Update 30 July 2026Early Clinical Data Shows Encouraging Safety Profile ProMIS Neurosciences Inc., a clinical-stage...
Latest Newsletter Post
-
ViiV Healthcare Shares New HIV Trea..
31 July 2026
-
Kaigene Licenses Autoimmune Drug Ca..
31 July 2026
-
MannKind Reports Positive Phase 1b..
31 July 2026
-
ProMIS Reports Positive Interim Pha..
30 July 2026
-
Bain Capital to Acquire Vitabiotics..
30 July 2026
